Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Labs gains on Q3 profit beat

** Divi's Laboratories  DIVI.NS  rises 4% to 5,385 rupees
    ** Pharma co reports 64.5% y/y jump in Q3 consol net profit
to 5.89 bln rupees ($67.6 mln), beating analysts' expectations
of 5.13 bln rupees, per data compiled by LSEG
    ** Rev from operations up 25% y/y
    ** Stock top gainer on Nifty Pharma Index  .NIPHARM , which
is down 0.3%
    ** DIVI was trading ~0.2% lower ahead of results
    ** Stock down 4% YTD vs 9% drop in NIPHARM

($1 = 87.0990 Indian rupees)

 (Reporting by Nishit Navin)
 ((nishit.navin@thomsonreuters.com;))

Recent news on Divi's Laboratories

See all news